News: Honours projects - Timothy Hughes
Efficacy of a combination of TKI and a novel allosteric inhibitor asciminib in chronic myeloid leukaemia
![Tim Hughes honours - asciminib](/sites/default/files/styles/ua_landscape/public/media/images/2019-09/hughes-honours-asciminib.png?h=6ef8a005&itok=nvsZtdkJ)
Honours project: Investigate the synergistic effect of the combination of TKI and asciminib.
Monitoring of minimal residual disease on chronic myeloid leukaemia patients in a setting of treatment free remission
![hughes honours myeloid leukaemia](/sites/default/files/styles/ua_landscape/public/media/images/2019-09/hughes-honours-myeloid-leukaemia.png?h=c223e903&itok=Fe0wMRtp)
Honours project: Characterise the residual leukaemia population in TFR patients, and understand why some patients relapse and others don’t.
Metabolic dependencies for improved therapeutic outcomes in chronic myeloid leukaemia
![hughes honours myeloid leukaemia](/sites/default/files/styles/ua_landscape/public/media/images/2019-09/hughes-honours-myeloid-leukaemia2.png?h=aaee32ba&itok=ao0qgvFJ)
Honours project: Participate in a novel and innovative approach will likely provide a combinational treatment strategy with greater efficacy than current approaches.